west midlands - wmahsn€¦ · delegate brochure 2016 4 i am delighted to be welcoming so many of...

WEST MIDLANDSACADEMIC HEALTH SCIENCE NETWORK

economic summit 2016

Delegate brochure 20162

Generating continuousimprovement in the region’s health and

wealth

Delegate brochure 2016 3

Contents

Foreword 4

Introduction 5

Agenda 6

Speaker and panel profiles 8

Seven point growth plan update 12

Economic impact 19

Celebration of Innovation Awards 20

Delegate list 21


I am delighted to be welcoming so many of you to the third annual Economic Summit, hosted by the West Midlands Academic Health Science Network (WMAHSN), and representing the rich mix of partners which is so vital to the work of the AHSN.

This event will focus on the repercussions of the vote to leave the EU and the impact of the West Midlands Combined Authority and local Sustainability and Transformation Plans (STPs) on the regional life sciences and healthcare sector, as well as the potential impact that these will have as economic drivers for growth and improving the health and productivity of the local population.

The decision to leave the EU marks the beginning of a new chapter for the UK, but the West Midlands is well-placed to confront the challenges ahead, thanks largely to the strength of the life sciences sector in the area. Coupled with this, the forthcoming devolution of England’s regions and STPs will bring together health and social care budgets, with joint decision-making on integrated care to support physical, mental and social wellbeing.

With the development of the West Midlands Combined Authority moving on apace, strategies will focus on the ambitious agenda set out in the NHS Five Year Forward View: keeping people well and as independent as possible, with more preventive work in the community and health and social care delivered closer to home, helping in the long-term to ease pressure on hospitals. Supporting this will be the West Midlands’ growing expertise in personalised healthcare and precision medicine, involving clinicians, patients, academics and innovators.

The healthcare and life sciences sector has been recognised as key to the growth of the economy. As well as sustaining employment across the West Midlands, a healthy population is more productive, more active in the economy and less dependent on

government support. In addition, the NHS locally can be a driver for economic growth, not just a consumer of GDP.

This summit will examine the impact that Brexit, devolution and STPs will have on the life sciences sector in the West Midlands, as well as the opportunities that it will afford, with the increasing focus on integration, prevention and economic growth. This is a chance to showcase the region’s life sciences and healthcare organisations and the many ways that they are contributing to wealth creation in the West Midlands, as well as dramatically increasing its international appeal.

These developments offer us an unheralded opportunity to build on regional strengths. The WMAHSN opens doors and creates a more conducive environment for relevant industries to work more effectively with the NHS and others in the UK healthcare sector, helping to accelerate access to new drugs, therapies, treatments, digital tools and ways of delivering healthcare.

I welcome the continued development of the WMAHSN’s seven point growth plan, which is delivering improved wealth and health for West Midlands residents. I also applaud the WMAHSN’s ambition to make this region an internationally attractive arena in which to discover tomorrow’s healthcare innovations, making personalised healthcare developed in the region into a sought-after product overseas.

I do hope that you find the summit both useful and interesting, and that it will enable you to learn more about the importance of economic impact in the healthcare sector and encourage you to be involved in shaping and designing health policy across the region.

Professor Michael SheppardChair, West Midlands Academic Health Science Network

Foreword

Foreword


A very warm welcome to you all to this, our third annual Economic Summit.

Our prime purpose continues to be improving health outcomes and generating wealth by driving the adoption of proven innovations at scale and pace. How we do this is threefold: the spread of innovation boosts inward investment and creates jobs in the West Midlands; the employability and productivity of the local population is boosted by innovations which improve healthcare or promote healthier living; and the local NHS is able to generate savings and operate more sustainably within its funding envelope.

Since last year’s summit, WMAHSN launched its enhanced membership scheme, offering further benefits and services which are already showing real economic impacts. The myriad of membership services and networks, including the Meridian health innovation exchange, provide an opportunity for co-production and collaboration that both feeds and informs innovation and improvement to deliver better healthcare outcomes and create economic growth across the West Midlands.

Our industry gateway, Medilink West Midlands, continues to support companies both inside and outside the West Midlands, providing them with regional and health sector knowledge to allow them to position their businesses more effectively in the UK health market. Furthermore, in order to be proactive in attracting, developing and rewarding the best talent in life sciences and healthcare, WMAHSN has also sought to influence the skills agenda, working through the industry gateway to develop sector-specific programmes to improve the existing knowledge base and develop future talent initiatives.

WMAHSN programmes have already safeguarded or created jobs, generated collaborations and

secured investment of over £4 million in the last year alone. WMAHSN has developed and managed a suite of investment funds to place over £1million of investment into small and medium enterprises (SMEs) and larger industry, including the SME Innovation Fund and the national Small Business Research Inititaive (SBRI) Healthcare fund. Importantly, last year almost £16 million of savings were achieved for the NHS.

These activities underpin the WMAHSN’s seven point growth plan, which sets out how the West Midlands will become an internationally attractive arena in which to do business and discover innovations. WMAHSN facilitates the development of a more economically effective health system, and you will hear an update on the progress of the plan today.

I feel strongly that with the involvement of local business leaders with NHS entities, academics, local authorities and third sector organisations, combined with our unique population and top-class facilities, this region is a beacon for innovative healthcare, improving not only the health outcomes of the West Midlands’ population, but also driving up its economy.

With the prospect of Sustainability and Transformation Plans, Brexit and devolution, these are exciting times for the West Midlands. I hope today’s summit will afford you a genuine opportunity to cement work with the WMAHSN and in so doing accelerate the adoption of innovation to generate continuous improvement in our region’s health and wealth.

Dr Christopher Parker CBEManaging Director, West Midlands Academic Health Science Network

Introduction


9.45am Registration

10.30am Introduction to the WMAHSN Economic Summit 2016Michael Sheppard, Chair, WMAHSN

10.45am Update on the seven point growth planTony Davis, Commercial Director, WMAHSN

11.05am Maximising global opportunities in the light of BrexitKevin Wilson, Sector Specialist, Department for International Trade

11.35am

Maximising global opportunities in the light of Brexit - Panel DiscussionChaired by Dr Peter Dirken, Strategic Partnership Manager, Innovate UK• Jerome Baddley, Head of Unit, Sustainability Development Unit for the Health and Social Care sector • David Calder, Knowledge Transfer Manager, Knowledge Transfer Network• Peter Dines, Investment Director, Head of Life Sciences, Mercia Technologies• Richard Stone, Chief Executive, Medilink West Midlands• Kevin Wilson

12.05pm Refreshment break and networking

12.45pm

Strategic opportunities of devolutionDr Linda Magee OBE, Business Development Director, Manchester Academic Health Science Centre and Executive Director, Industry and Wealth, Greater Manchester Academic Health Science Network

1.10pm

Strategic opportunities of devolution - Panel DiscussionChaired by Dr Adrian Phillips, Director of Public Health, Birmingham City Council• Dr Linda Magee OBE• Dr Jane Moore, Director of Public Health, Coventry City Council• Geraldine Strathdee, former Clinical Director for Mental Health, NHS England• Dr Clive Winters, Associate Pro-Vice-Chancellor (Public Relationships), Coventry University

1.40pm Lunch and networking

2.40pm Introduction to the afternoon sessionTony Davis

2.45pm

Sustainability and Transformation PlansThe Local Authority Perspective: Mark Rogers, Chief Executive, Birmingham City CouncilThe Clinical Commissioning Group Perspective: Andy Williams, Accountable Officer, Sandwell and West Birmingham CCG and Lead, Black Country Sustainability and Transformation Plan

3.10pm

Sustainability and Transformation Plans - Panel DiscussionChaired by Alison Tonge, Director of Commissioning Operations, NHS Midlands and East• Mark Rogers• Andy Williams• Terry Whalley, Programme Director, Black Country Alliance

3.50pm Closing remarksTony Davis

4pm Event close

Agenda

Agenda


DO YOU HAVE A HEALTHCARE INNOVATION OR CHALLENGE?

THEN WHY AREN’T YOU USING MERIDIAN?

Join the Meridian community for free now at [email protected] | @wmahsn | 0121 371 8061

Meridian is the pioneering online innovation exchange for the

healthcare community from the

West Midlands Academic Health Science Network.

Anyone - including from the NHS, academia, industry,

public and the third sector - can share their innovations and

ideas, swap success stories, build networks and contact

others whose innovations could revolutionise healthcare in the

West Midlands.

Users can also upload their healthcare challenges and needs via campaigns, inviting solutions through

new or existing innovations, speeding up the adoption

and spread of good practice across the region.

Join the Meridian community for free now at [email protected] I @wmahsn I 0121 371 8061


Jerome Baddley, Head of the Sustainable Development Unit for the Health and Social Care system in England The Sustainable Development Unit is funded by Public Health England and NHS England to work across the health and social are system supporting and encouraging the integration of the principles of sustainable development (environmental, social and economic sustainability). Jerome has worked for 17 years in sustainable development, with 10 years in leadership roles, most recently as Chief Executive of an environmental social enterprise and Low Carbon Sector Chair of a Local Enterprise Partnership (LEP) in the East Midlands.

He led a team to produce the first full NHS carbon management plans in 2008, the Nottingham City 2020 Energy Strategy in 2010, and the regional natural resource footprint for the NHS in the East Midlands in 2012. He has spent 10 years supporting health and social care organisations, businesses, third sector and communities to implement strategic and practical measures in sustainable development and resource efficiency. He is a past winner of the Queen’s Award for Enterprise in Sustainable Development and the BMJ global award for Sustainable Healthcare.

David Calder, Knowledge Transfer Manager, Knowledge Transfer Network UK (KTN-UK)David is a Knowledge Transfer Manager for KTN-UK, working primarily in health technology. His current role provides support to UK R&D-intensive businesses working in health and social care innovation, including responsibility for KTN-

UK activity in digital healthcare and high value manufacturing (health technologies).

His background is in manufacturing and product development in electronic components and filtration, as well as cross-sector R&D and project management.

Tony Davis, Commercial Director, West Midlands Academic Health Science NetworkTony is the Commercial Director for the WMAHSN, a partnership bringing together NHS commissioners and providers, academia and industry, uniquely placed to support the NHS in increasing its contribution to both health improvement and the economy. He also leads the wealth creation enabling theme. He was previously Executive Director of the WMAHSN on its establishment. Before his role at the AHSN, Tony launched Medilink West Midlands Ltd in 2003, with the aims of promoting the life sciences industry to government organisations and helping SMEs in the marketplace to grow their business. In 2005, he was appointed the first chair of Medilink UK.

Peter Dines, Investment Director, Head of Life Sciences, Mercia TechnologiesAs a highly successful entrepreneur and investor, Peter brings 20 years’ experience in the healthcare sector, holding numerous directorships across a wide range of life sciences businesses.

Over this period, Peter has been involved with a number of high profile turnarounds and exits within the sector, including the acquisition of Surgicraft’s

Speaker and panel profiles

The WMAHSN leads, catalyses and drives co-operation,

collaboration and productivity between academia, industry,

health and care providers and commissioners, and citizens


loss making business where, as Managing Director, sales quadrupled within three years and the business subsequently sold to ISIS Equity Partners. Other key healthcare positions held, both previously and currently, include Bridges Ventures, Cisiv, Diagnostic World, Spring Active and Newtech Ortho.

Dr Peter Dirken, Strategic Partnership Manager, Innovate UKPeter is responsible for managing the portfolio of Knowledge Transfer Networks, Innovate UK’s business-to-business and academia-to-business innovation networks. He has managed high-tech projects and programmes for private business in the past, including Johnson Matthey and Oxford Instruments. Peter also managed a project team at JET, the world’s largest nuclear fusion reactor in Oxfordshire.

Dr Linda Magee OBE, Business Development Director, Manchester Academic Health Science Centre (MAHSC) and Executive Director, Industry and Wealth, Greater Manchester Academic Health Science Network (GMAHSN) Linda is jointly appointed across MAHSC and GMAHSN to support industry collaboration and economic development. She served as Chief Operating Officer at MAHSC from its initiation in 2009 and when it expanded in 2013 she became Business Development Director. Linda is also a member of the operations executive of the NIHR Greater Manchester Comprehensive Local Research Network (CRN) and the Health Innovation Manchester Business Engagement Group. MAHSC, GMAHSN, CRN and the LEP, along with industry, have come together under ‘Devo Manc’ to improve the discovery, development and delivery of innovation into healthcare.

Prior to joining MAHSC in 2009, Linda was Biotechnology Sector Director and established Bionow®, the biomedical cluster supporting economic development for the North West Development Agency (NWDA). Before this, she was co-founder and General Manager of Manchester Biotech Ltd, the UK’s first dedicated biotechnology incubator company, at the University of Manchester (now part of UMI3). She also developed and directed the £35 million National Biomanufacturing Centre project while at the NWDA, now managed commercially by Allergan.

Following a PhD in Medical Biochemistry at the University of Southampton, Linda worked for a US healthcare company, Pall Biomedical, in technical and marketing management positions. She was awarded an OBE in the Queen’s Birthday Honours 2009 for services to biotechnology.

Dr Jane Moore, Director of Public Health, Coventry City Council A former cluster Director of Public Health for Outer North East London, Jane has worked in public health at regional level in London, leading on aspects of the transition of public health function to Public Health England, screening and public health incidents. Jane has also worked in a number of non-public health roles that reflect her interest in how to improve care for individuals and maximise health and wellbeing outcomes. She has also been regional lead on health inequalities for the south west region and her areas of public health interest are health inequalities, the involvement and empowerment of communities and individuals and how we improve the quality of care and outcomes for individuals.

Dr Adrian Phillips, Director of Public Health, Birmingham City CouncilAdrian qualified in medicine from the University of Birmingham in 1985. He spent his formative years in acute hospital medicine treating many avoidable illnesses, especially coronary heart disease, lung cancer and chronic lung diseases. Adrian then specialised in population medicine and completed his training in public health in 1997. He was appointed Joint Director of Public Health at Wolverhampton in 2000 and moved back to Birmingham in October 2012, again as Director of Public Health.

Mark Rogers, Chief Executive, Birmingham City CouncilIn March 2006, Mark joined Solihull Council’s Corporate Leadership Team, having been appointed to the post of Director of Children’s Services. This role provided the unmissable opportunity to take forward the Council’s trailblazing work as a Children’s Trust Pathfinder, developing a fully fledged Children & Young People’s Partnership for improving outcomes. During his time at Solihull, the council introduced a highly regarded integrated transformation and organisational development programme which, through the application of Lean Thinking, put citizens and digital innovation at the heart of the drive for greater quality and value.

In December 2013, Mark was appointed to the role of Chief Executive and Director of Economy at Birmingham City Council and took up the role in March 2014. These combined roles are designed to have maximum impact on the three priorities of prosperity, fairness and democracy, ensuring Birmingham continues to live up to its status as a growing, international city. Mark maintains his commitment to children’s services as the Society of Local Authority Chief Executive’s lead for this field, a role involving being a deputy chair of the


Social Work Reform Board up to 2012, becoming co-chair of the new national Children’s Health and Wellbeing Partnership in 2013, and jointly founding the Children’s Improvement Board (2010-13) which set the framework for sector-led improvement in children’s services.

Professor Michael Sheppard, Chair, West Midlands Academic Health Science Network Michael served most recently as Provost and Vice Principal and Dean of Medicine at the University of Birmingham. He received the degrees of MBCHB (Honours) and PhD from the University of Cape Town. He was elected Founder Fellow of the Academy of Medical Sciences in 1998.

Michael had a major clinical service commitment and international reputation in pituitary and thyroid disease, publishing more than 250 papers. He has been a member of and chaired a number of UK and international committees (endocrine societies, Royal College of Physicians, Medical Research Council and World Health Organization). He was President of the Association of Physicians of Great Britain and Ireland and holds Honorary Professorship at the University of Birmingham. He was previously a non-executive director (NED) at Birmingham Children’s Hospital NHS Foundation Trust and University Hospitals Birmingham NHS Foundation Trust and and is currently a NED at Heart of England NHS Foundation Trust.

Richard Stone, Chief Executive, Medilink West Midlands Richard has been Chief Executive of Medilink West Midlands since October 2014, having previously been Operations Director of the company since 2008. With responsibility for the organisation’s operational functions, Richard has successfully developed and implemented proprietary processes and procedures, ensured delivery of supportive and complementary commercial activities and overseen delivery of public sector contracts valued in excess of £8.6m.

Richard has more than 25 years’ experience of management roles within manufacturing industries, including marketing, sales, finance and operations, and led an SME in the development, production, manufacturing, marketing and worldwide sales of a disposable medical product. He is qualified with the Chartered Management Institute and the Chartered Institute of Personnel and Development, and holds a Master’s degree in Business Administration.

Geraldine Strathdee, former Clinical Director for Mental Health, NHS EnglandGeraldine was previously NHS England’s National Clinical Director for Mental Health and is a consultant psychiatrist. She co-chairs the National Mental Health System Board, which brings the new system partners together to implement the

national mental health strategy. She is the clinical lead for the Mental Health Intelligence Network and the national clinical commissioning group mental health leadership programme.

Previous roles have included National Professional Adviser to the Healthcare Commission and Care Quality Commission, and London Strategic Health Authority Mental Health Lead. She was awarded the prestigious Psychiatrist of the Year award in 2012.

Alison Tonge, Director of Commissioning Operations, NHS Midlands and East Alison has spent most of her career working in commissioning, consulting and provider roles, with a period in Canada with a large integrated provider. She brings an emphasis on strategic change and driving sustainability. Employed since 2012 in NHS England in a range of senior positions, including specialised services, she is now in the West Midlands as the lead for the commissioning system and overseeing the system-wide plans for sustainability, working closely with partners.

Alison is a qualified accountant and value manager, and is trained in consulting and large scale programme delivery.

Terry Whalley, Programme Director, Black Country Alliance Terry has spent his career enabling transformational change in a variety of private and public sector organisations, including insurance, banking, utilities, private healthcare and most recently the NHS. Terry studied at the Harvard Kennedy School, Harvard School of Public Health and the Institute of Health Improvement in Boston as part of the prestigious NHS Executive Fast Track Programme. He is presently Programme Director for the Black Country Alliance, a new model of acute care collaboration between Sandwell and West Birmingham Hospitals NHS Trust, Dudley Group NHS Foundation Trust and Walsall Healthcare NHS Trust, which has its focus on long term clinical and financial sustainability through collaboration.

His previous roles have included Project Director at Wirral University Teaching Hospital NHS Foundation Trust, where Terry helped to shape what became a successful vanguard bid with clinical commissioning group, community trust, mental health trust and local authority partners, as well as leading the trust’s response to issues associated with emerging multi-drug resistant organisms.

Prior to joining the NHS, Terry worked at Bupa, helping large corporate organisations and their advisors form health and wellbeing strategies and helping Bupa shape its portfolio of products and services to meet those corporate needs. Prior to this, Terry spent time with a number

Speaker and panel profiles


of global organisations including Aviva, National Grid, Cooperative Financial Services and Barclays Bank, where he established their global payments infrastructure and service delivery function and helped deliver infrastructure and services which now underpin their Faster Payments network.

Andy Williams, Accountable Officer, Sandwell and West Birmingham Clinical Commissioning Group (CCG) and Black Country STP lead Andy has worked in the NHS for thirty years, with over half of those at director or CEO level. Andy has been the Accountable Officer of Sandwell and West Birmingham CCG since its first wave authorisation in 2012. During that time, he has led the organisation to four national awards, including twice being named CCG of the year by the Health Service Journal.

Andy has been the senior responsible officer for a number of major service reconfigurations, including obstetric services in Sandwell and West Birmingham, stroke services across Birmingham and the Black Country and the Right Care Right Here partnership which culminated in approval to build the new Midland Metropolitan Hospital.

Andy’s regional roles include co-ordinating commissioner for ambulance services and NHS 111 for 22 CCGs in the West Midlands, covering 5.4 million people. He is the chair of the West Midlands Urgent and Emergency Care Network and is the lead for the Black Country STP. Andy is also a Chartered Fellow of the Institute of Personnel and Development, a member of the Institute of Health Management and has an MBA (Health) from the University of Nottingham.

Kevin Wilson, Sector Specialist, Medical Technologies and Life Sciences Organisation, Department for International Trade Kevin has more than 35 years’ experience in the life sciences and medical technology sector and is currently a Sector Specialist on behalf of the Department for International Trade for medical technology, providing advice to government agencies and UK companies on both international trade and inward investment opportunities. A “Globalscot”, Kevin has extensive contacts internationally, in particular with Brazil, China and the USA.

Throughout his career, Kevin has held board level and senior management roles with Johnson & Johnson, Sherwood Medical, NMT safety products and AorTech Critical Care. He spent five years as CEO of Medical Devices in Scotland, the medtech industry association.

Kevin also has a mini MBA in medical technology management from the University of St Thomas Center for Health and Medical Affairs, Minnesota. He sits on the Scottish Medical Technology Steering Group and is a Director of Innova Partnerships Ltd,

a Scottish-based life sciences business growth company.

Dr Clive Winters, Associate Pro-Vice-Chancellor (Public Relationships), Coventry UniversityClive is a double graduate of Coventry University with a background in manufacturing systems engineering and supply chain management. As a director of Coventry University Enterprises since 2003, he has led the design, development and delivery of business-university co-operation, innovation, enterprise and entrepreneurship projects in the UK and Europe. Alongside this, he has delivered expert consultancy on regional innovation strategies, university-business co-operation, science and technology park development, business incubation and smart specialisation.

Recognised for his ability to lead and successfully deliver high-level strategic innovation projects, Clive has worked closely with government departments and political and organisational leaders on the development of local strategies and policy (in particular the Coventry and Warwickshire LEP) and with the public and private sector on the development and delivery of major programmes and initiatives.

Clive is a strategic advisor to Coventry and Warwickshire LEP and Chair of the West Midlands Combined Authority Innovation Group.


Growth Plan Update

The West Midlands Academic Health Science Network

wealth creation seven point growth plan


The West Midlands Academic Health Science Network

wealth creation seven point growth plan

Katie Judge, Executive Officer for GBS LEP, described the importance of the life sciences strategy: “Informed by the findings and recommendations of the Greater Birmingham Life Sciences Commission, the Silk Report, GBSLEP has brought NHS, academic, industry and public sector partners together to drive forward a commercially focused strategy for growing the life sciences sector that will capitalise on the region’s strengths in translational medicine, and build on the success of the accelerated trials infrastructure developed in haematology. We believe that Greater Birmingham’s offer to the life sciences industry has the potential to attract global investors, increase exports, create both public and private sector jobs and improve the health of our population.

“At the same time, we can accelerate the rate at which patients can try new treatments which will have significant economic benefits. The unique demographic make-up of the West Midlands and our world-class healthcare makes us the ideal choice for trials, utilising our concentration of assets within Birmingham.

“Working alongside the WMAHSN on the Leadership Panel, we’re collaborating with academics and healthcare professionals in Oxford to create a new system bringing together discovery and trials. With HS2 arriving, this is the right time to take advantage of our assets and networks.”

Founder Richard Westman chose the West Midlands for its wealth of support and opportunities. Richard explained: “This is the place we wanted to be. Birmingham is a developing tech city and has all the foundations in place to help us be successful.

“The team at the WMAHSN has been brilliant in helping Kaido to grow a relevant network and establish a name for ourselves in the Midlands. We knew selling into the NHS would be tough, thus we needed to build an appropriate network to establish credibility in the space. Microsoft, Pfizer and Proctor & Gamble are all big names supporting Kaido and they have given my shareholders the confidence to invest. We are an extremely agile and fast moving start-up business and this has been facilitated by the WMAHSN.”

Based in Birmingham’s Serendip® Digital Health Quarter, Kaido is part of the incubator programme, a beneficiary of the SME Innovation Fund and more recently, received €50,000 from the European Institute of Innovation and Technology (EIT) Health Headstart and Proof of Concept funds. .

Richard continued: “Another huge attraction for setting up Kaido in Birmingham is the Queen Elizabeth Hospital, a pioneer for patient-centred care, which is a great fit for our technology. Receiving funding from the SME Innovation Fund provided a unique opportunity to work with University Hospitals Birmingham to pilot a staff wellbeing programme using our platform. We are hoping to develop a convincing evidence base for improved health outcomes from our platform over the coming months.”

The WMAHSN has helped us to establish a network that I just don’t think we could have benefitted from elsewhere. Now, we have an incredible opportunity to make stuff happen.

We will at all times promote the West

Midlands as the place to invest and deliver

life sciences and healthcare innovation

Start-up healthtech firm Kaido Group Ltd is developing the first artifically intelligent health insights platform. The Kaido platform uses big data and professional health expertise to empower individuals and businesses to understand their health better.

“

“

We are committed to build on existing

strengths and partnerships between

universities, the wider research base,

industry and the NHS to establish a cohesive system of

translational research and development

We’re increasingly looking at what can be developed across the West Midlands and it is very important to us that we work with NHS trusts and industry in the region. The WMASHN is a critical partner in engaging NHS trusts and industry partners across the West Midlands to develop a strong regional offer.

Headquartered in the new Institute of Translational Medicine (ITM), a world-class clinical research facility built using local growth funds secured by the Greater Birmingham and Solihull Local Enterprise Partnership (GBS LEP) and Birmingham Health Partners, the WMAHSN is perfectly placed to maximise collaborative opportunities.

““


Now Solihull College is offering new courses and the WMAHSN is working with them to demonstrate the appeal of a career in the sector. To do that, we need to explain to young people what a career in life sciences could involve, the job opportunities available for them and how they can get the skills they will need to progress. The WMAHSN has already been involved in four workshops that offered careers advice and demonstrated the skills that employers will be looking for, giving students a valuable insight into what a career in healthcare or life sciences will really look like for them.

Nurturing a workforce with the skills that are needed to work in the life science sector has been a key priority for Greater Birmingham and Solihull Local Enterprise Partnership (GBSLEP). Sitting on the Education and Skills Board (ESB) as a sector skills champion, the WMAHSN has been actively identifying employer needs and developing a life sciences skills action plan.

“

“

We will be proactive in attracting,

developing and rewarding the best

talent in life sciences and healthcare

Julie Robinson, CEO at Move it or Lose it, first engaged with theWMAHSN on its Meridian health innovation exchange; “We’ve had fantastic feedback from our first pilot programme for the NHS, providing weekly fitness classes for patients with COPD, for four Birmingham-based GP practices. People reported feeling stronger, more energised, more confident and needing less medication. We thought Meridian was a great opportunity to share those results with other healthcare professionals, as we believe our programme has the potential to improve the wellbeing and therefore the productivity of a hard-to-motivate section of the population.”

Following exposure on the Meridian platform, Move it or Lose it was invited to apply for SMEInnovation funding. “We have been granted £50,000,” explained Julie, “which will help usdevelop the tech side of our business. We wantto improve our evaluation of the data we collectand boost our programme with an app that canhelp provide personalised support at home, inbetween classes. We believe that this will makeit an easy decision for CCGs who want tocommission these services.”

By improving the fitness and emotional wellbeing of people with long term conditions, we believe we can help CCGs save money on medications and hospital admissions. Most importantly, we’ll be making people more able to work and enjoy life. We know that the WMAHSN has the contacts and experience of the market to help us reach out to health professionals. They are our foot in thedoor.

We will work with the entire

life sciences and healthcare innovation ecosystem to produce a regional population

that is more productive and more economically active

From the Combined Authority’s consortium for demonstration of intelligent systems (CDIS) to the SME Innovation Fund, the WMAHSN is developing several routes to support all types of organisation that can help members of the public to manage their own health and wellbeing.

“

“

Chair of the ESB, Andrew Cleaves, explained: “As our sector skills champion, the WMAHSN is our eyes, ears, intelligence and knowledge source, helping us identify the job roles that are needed now and the ones that will be needed by the life sciences sector in the coming years. The skills plan that’s been developed earlier this year sets out the top five actions we can take to raise aspirations and skills levels to work within life sciences. We can also use Local Growth Funding secured by GBSLEP to enable local skills providers create the infrastructure and equipment that we need to make them happen.

“While many students and their families are familiar with the traditional pathways through education and into employment, we are working with the WMAHSN to develop both higher education and further education routes. Vocational routes are a stepping stone and the experience gained through higher level apprenticeships can help students secure real jobs or prepare them for further education. There’s work to be done, but the new apprenticeship levy in the NHS should help everyone recognise the opportunities that higher apprenticeships can offer.

“Colleges have welcomed our approach and are keen to access the WMAHSN’s experience and network, to gather ideas and suggestions for what courses should cover and what facilities are required. At Solihull College, the LEP provided Local Growth Funding to create an area focused on life science courses and the WMAHSN recommended the selection of essential equipment and new technology that will help equip students with skills for now and the future.”

Seven point growth plan update


Jerome Baddley, Head of the NHS Sustainable Development Unit, is working with AHSNs and Medilink UK to embed new technologies and ways of working in the NHS to reduce the harm it does to communities and the global ecosystem. “Not many devices are being promoted for theirsustainability,” said Jerome, “but it’s very important in the NHS’s procurement and commissioning processes. We are looking at the critical paths that we need to address this issue and make the UK a world leader in sustainable medical devices. As the world tries to catch up, we’re keen to promote links with industry that develop an economic model for sustainability. “It’s not all about new buildings. Take, for example, the inhaler market. This represents 3.5 per cent of the NHS’s carbon footprint. We’ve helped pioneer a scheme to capture the gases after use, but we want to make an impact at the start of the cycle.

“The WMAHSN understands the role the NHS has in wider society and the impact that society has on the NHS. Addressing the root cause of issues can help crack this co-dependency. Look at air quality. The NHS can encourage more sustainable transport and travel planning. This can improve air quality in a community, which could prevent thousands of needless deaths and save the NHS thousands of pounds in treatment. The WMAHSN sits in the middle of this, with a network of suppliers, NHS staff and academics that can push for change. They can help us promote the environmental agenda, not just the health agenda.”

The WMAHSN can help us raisedemand and awareness for sustainability through its network and there’s an opportunity here to drive an innovation that has significant environmental and social impact.

We are committed to working with both

the NHS and local authorities in the

adoption of innovation and best practice, to improve their

productivity, in turn empowering them to deliver more health benefit for a given

public resource

‘Do no harm’ is a cornerstone for practitioners in the NHS. But it’s not just relevant to clinicians. As the fifth largest employer in the world and employer of 10 per cent of the UK workforce, the NHS has a huge role to play in setting best practice and its carbon footprint has significant global impact.

“

“

Identifying the product’s global potential, the WMAHSN will be hosting the OrthOracle at Arab Health in Dubai. Mark commented: “Arab Health is the biggestshowcase for healthcare in the Middle East and it attracts a global audience. This is an opportunity to start new relationships and explain our educational offer. We believe there will be an appetite from other countries for a UK-built, high quality, validated educational tool.

“As well as providing us with a global platform, the WMAHSNhas also identified some sources of funding to help us create additional educational features and to redesign and translate the site. We already have 60 operations, detailed with high resimagery, generated by leading consultants and validated byour invited editorial board. With this funding, we’ll be expanding this, developing professional training modules and working with colleges for validation. The WMAHSN team is helping us identify our priorities for translation and as a result of their guidance, we’ll be starting with Spanish and Chinese to assess the initial interest from these markets. As well as recognising the clinical benefits of our product, the team is aware of what we need to achieve commercially. By implementing these developments, we can be first in the field, making us a more attractive proposition for industry and sponsorship.”

We know that relationships are built over time and we’re hoping to use the WMAHSN’s network to meet with reputable medical schools, institutions, hospitals and digital health companies to move our plans forward. OrthOracle is not just a website, it’s a gathering of world-class clinicians - and that gives us enormous scope to develop the OrthOracle into a meaningful simulation product and a living, responsive resource that can promote and disseminate best practice instantly, across the world.

We will endeavour to support the export of innovation, ideas and experience globally and will also work with UK industry in

providing new global market opportunities

Combining experience, ideas and innovation in one educationalplatform, Consultant Orthopaedic Foot and Ankle Surgeon Mark Herron has created the OrthOracle, a unique collaboration between world-leading practitioners.

“

“


Seven point growth plan update

“We’re getting stuff done,” said Bethan Bishop, entrepreneur in residence at Serendip. “Support from the WMAHSN means that we can help aspiring companies access funding which bridges the gap between concept and commercialisation. I love working with these companies. I’m able to share NHS insight, which seems the norm to me, but it’s important knowledge for a start-up. We do some myth-busting. And we don’t waste people’s time. We’re here to advise and do due diligence, to ensure that every idea meets a real NHS need, and encourage firms to go through the discipline of interrogating their business plan. I hate duplication and even if it means killing ideas, I’ll help companies focus on the areas that are actually needed. For each bid, companies must lay out a project, commit to milestones and examine their business plan at a granular level.”

It’s really early days, but the WMAHSN is helping us think about accessing finance, putting us in touch with a few people, helping us secure centrally-located office space for free and supporting the testing of our product. I believe we can achieve a step change and accelerate the growth of our service. They’rehere when we need them.

““

We will facilitate thedevelopment of a more economically effective

health system, with an AHSN supporting

‘lead customer’ activity

As collaboration is at the heart of these plans and the West Midlands already has many initiatives in place that have similar goals, the WMAHSN identified an opportunity to share its knowledge and network to help each planning team maximise on the work that’s already been done. Building on its commitment to work with industry bodies and large healthcare firms, the WMAHSN approached Pfizer to provide a dedicated resource, which could develop a support package for each STP footprint.

“We began by mapping our stakeholders,” explained Laura Pakel, strategic account consultant at Pfizer. “We have been looking at the environment as a whole and identifying any priorities. It was an opportunity to begin the process of engagement and reach out to different sectors and communities in the region. There was a lightbulb moment when we realised how diverse our stakeholder list had become. Ranging from the police to local businesses, it’s clear that this is an opportunity to integrate the strategy for the NHS into its communities.

“I know from my work at a large pharmaceutical company how important communications and marketing will be to facilitate each plan. Working with such a diverse group and ensuring proper engagement will take time, and we’ve identified lots of ways that the WMAHSN will be able to help. We’ve developed a communications plan and will be publishing it soon.”

WMAHSN could offer most support: financially – to help reduce costs and increase income; improvement – to deliver better and safer services; and innovation – to match solutions to needs.

The WMAHSN is starting to direct key stakeholders towards the new offer, by attending forums and through the Membership Innovation Councils. Our ultimate aim is to shine a spotlight on this activity, to offer the support that is needed and combine all our experience to accelerate the delivery of the Five Year Forward View. Everybody needs to be involved – and that includes the WMAHSN.

Every local health and care system in the country, including the West Midlands, has come together to form six Sustainability and Transformation Plans (STPs), an initiative by NHS England to accelerate the implementation of the Five Year Forward View.

“

“

“We’re interested in tech opportunities to make healthcare more joined up,” said Mahnaz Hashmi, co-founder of Serendip® Digital Health Quarter tenant Medstars. “Patients are supposed to have choice about who to go to for treatment, but how can they make that decision? Our service is about the clinicians, not the hospitals. We match patient need with clinical expertise, using peer to peer technology. We’ve started in private healthcare, but we believe our model will work effectively in the NHS, helping patients make informed choices about the consultants that they choose to visit.”

It’s an experience that can be the difference between a company doing something, or not.

““


Coming out in Spring 2017 BQ West Midlands will be publishing a major 48 page BQ2 special report

LIFE SCIENCES AND HEALTHCARE IN THE WEST MIDLANDS

in association with WMAHSN

Contact us to discuss the commercial opportunities available or reserve your free copy [email protected] or [email protected]


To contact us and find out more:

[email protected] | www.wmahsn.org | @wmahsn | 0121 371 8061

To discuss the features and benefits of enhanced membership, contact Farana Akhtar, Membership Co-ordinator, on

[email protected] or 0121 371 8053

Have you discovered the benefits of enhanced membership yet?

WMAHSN offers an enhanced membership scheme, with additional benefits, services and premium access, in

return for a small contribution from NHS and academic organisations.

This will provide you with a series of tools and practical support to accelerate the adoption of innovative technologies and service approaches.

These benefits will advantage you in feeding and informing innovation, improving healthcare outcomes and achieving economic growth across the West Midlands.

The WMAHSN is also developing a corporate partnership scheme for larger industry members.

Benefits of enhanced membership Readymade innovation tools and resources Membership of MidTECH, the NHS innovation hub

for the West Midlands, worth £5,000 per year Premium access to Meridian, the online

healthcare innovation exchange, and Meridian training Access to all services and networks Practical advice and support available via phone, email or a

visit from one of our experts Access to the medicines optimisation component Access to the EIT Health KIC communities and

opportunities to bid for EU funding Opportunities to attend WMAHSN events The chance to enter our Celebration of Innovation Awards

and gain recognition Enhanced starter pack with contacts, guides and other

useful information An enhanced communications package, including reduced

sponsorship and advertising rates, joint PR opportunities and use of the WMAHSN enhanced membership logo.

>

Giving organisations in the West Midlands a competitive edge

>


To contact us and find out more:

[email protected] | www.wmahsn.org | @wmahsn | 0121 371 8061

To discuss the features and benefits of enhanced membership, contact Farana Akhtar, Membership Co-ordinator, on

[email protected] or 0121 371 8053

Have you discovered the benefits of enhanced membership yet?

WMAHSN offers an enhanced membership scheme, with additional benefits, services and premium access, in

return for a small contribution from NHS and academic organisations.

This will provide you with a series of tools and practical support to accelerate the adoption of innovative technologies and service approaches.

These benefits will advantage you in feeding and informing innovation, improving healthcare outcomes and achieving economic growth across the West Midlands.

The WMAHSN is also developing a corporate partnership scheme for larger industry members.

Benefits of enhanced membership Readymade innovation tools and resources Membership of MidTECH, the NHS innovation hub

for the West Midlands, worth £5,000 per year Premium access to Meridian, the online

healthcare innovation exchange, and Meridian training Access to all services and networks Practical advice and support available via phone, email or a

visit from one of our experts Access to the medicines optimisation component Access to the EIT Health KIC communities and

opportunities to bid for EU funding Opportunities to attend WMAHSN events The chance to enter our Celebration of Innovation Awards

and gain recognition Enhanced starter pack with contacts, guides and other

useful information An enhanced communications package, including reduced

sponsorship and advertising rates, joint PR opportunities and use of the WMAHSN enhanced membership logo.

>

Giving organisations in the West Midlands a competitive edge

> MERIDIAN

617 COMPANIES

Long terms conditions: a whole system, person-centred approachAdvanced diagnostics, genomics andprecision medicine

Mental health: recovery, crisis and preventionWellness and prevention of illness

HEALTHCHALLENGES21posted on the Meridian health innovation exchange,seeking industry solutions 13

INDUSTRY JOBS

created so far

12

INNOVATIONSintroduced to the WMAHSN)

exploring AHSN opportunities

employees engaged in WMAHSN activities (event attendees)

NHS

756

85 615INNOVATIONSgoing through commercialisation

industry innovations shared


industry innovationsshared


27

26

INNOVATION SUBMISSIONS

HEALTH INNOVATIONEXCHANGE

71

West Midlands Academic Health Science Network

With support from the industry gateway Medilink West Midlands, the WMAHSN has delivered a sigificant impact for its members, stakeholders and partners

1.

2.

3.

4.

since March 2016

Economic impact


Celebration of Innovation Awards 2016

On 30 June 2016, 180 people from across the West Midlands’ NHS, industry, academia, third sector and patient population gathered at the University of Warwick for the West Midlands Academic Health Science Network’s very first Celebration of Innovation awards.

The awards ceremony was the centrepiece of our annual stakeholder event, which brought to life the 2015-16 Annual Report and showcased programmes supported and introduced by the WMAHSN over the past 12 months.

The awards were established to recognise and celebrate the work of individuals and organisations in developing better healthcare and increasing wealth for local people. With categories for the Innovator of the Year Award and the Innovative Organisation of the Year Award, as well as prizes for Digital Health, Person-centred Care, Wealth Creation, Clinical Trials and Evaluation, Patient Safety and Education and Skills, the ceremony provided an opportunity to celebrate achievements from across the West Midlands.

“More than 80 entries were submitted across the eight categories. While it was a very tough decision to name the winners in the light of such a strong field, the other judges and I were in agreement that all of the entries showed an astonishing breadth of scope and approaches that were truly innovative, transforming patient care,providing solutions tosignificant challenges andbreaking down barriersacross our region. It wastruly inspiring to be involvedwith judging the awards,and I am already lookingforward to next year’sWMAHSN innovationawards with enthusiasm!”

Dr Christopher Parker CBEManaging Director, WMAHSN

And the 2016 winners were...Clinical Trials and Evaluation AwardCollege of Medical and Dental Science, University of BirminghamEducation and Skills Innovation Award Department of Intensive Care Medicine, Royal Stoke University Hospital and Keele UniversityDigital Health Innovation AwardBreaking Free GroupPerson-centred care Innovation AwardPrime GPPatient Safety Innovation AwardWolverhampton Clinical Commissioning GroupWealth Creation Innovation AwardUniversity Hospitals Birmingham NHS Foundation TrustInnovative Organisation of the YearMidlands and Lancashire Commissioning Support UnitInnovator of the YearAlan Press, Chief Executive, Kimal Plc

WMAHSN, its partners and the public will celebrate the region’s

success as a centre for innovation, health and wealth and as the first digitally-enabled health economy

in England


Forename Surname OrganisationAnis Ahmed Birmingham and Solihull Mental Health NHS Foundation

Trust

Farana Akhtar West Midlands Academic Health Science Network

Sam Alsop-Hall Harvey Nash PLC

Elizabeth Amini Birmingham and Solihull Mental Health NHS Foundation Trust

Sarah Appleby Health Education England (West Midlands)

Jerome Baddley Sustainable Development Unit for the Health and Social Care sector

Jane Ball Worcestershire Acute Hospitals NHS Trust

Clive Bawden Breaking Free Group

Anita Belton Serco Employment Skills and Enterprise

NimishKumar K Bhatt TEDxLeicester

Paul Bird CLAHRC West Midlands

Bethan Bishop Aliciyo

Edwin Borman The Shrewsbury and Telford Hospital NHS Trust

Amy Boulton West Midlands Academic Health Science Network

Pauline Boyle NIHR CRN West Midlands

Margaret Brewer Go To My Doctors Ltd

Neil Bryant Institute of Digital Healthcare

Ben Buckley Kaido

Dave Burrows Damibu

Stephen Bushell Probrand Group

Stephen Butterworth Worcestershire Local Enterprise Partnership

David Calder KTN

Beverley Campbell Excel To Excellence Limited

Ruth Chambers Stoke-on-Trent CCG

Matt Chapman KTN

Lucy Chatwin West Midlands Academic Health Science Network

Luke Cheesbrough CLAHRC West Midlands

David Clarkson IBM UK Ltd

Sinead Collinge CRN West Midlands

Nick Comley Beacon Centre for the Blind

Anne Coufopoulos Coventry University

Angela Crossland Coloplast

Kate Da Costa Janssen

Elizabeth Davies-Ward University of Worcester

Tony Davis West Midlands Academic Health Science Network

Blair Davis Birmingham and Solihull Mental Health NHS Foundation Trust

Caroline Davis Serco Employment Skills and Enterprise

Delegate list


Forename Surname OrganisationCatherine Dexter CRN West Midlands

Peter Dines Mercia Technologies

Gemma Dixon Birmingham City University

Julia Eades Roche Diagnostics

Sophie Emanuel Black Country Alliance

Nicola Evans Keele University

Claire Fenlon University of Birmingham

Trevor Fossey NHS Improving Quality

Elsie Gayle Mimosa Midwives

David Gittings Hill-Rom

Christopher Golby Evolyst Ltd

Lorna Green Innovation Agency

Lynne Griffiths Profile Pharma

Mark Guset Healthwatch Sandwell

Theresa Haddon West Midlands Food Links

Anna Hargrave NHS South Warwickshire CCG

Vicky Harris Dudley and Walsall Mental Health Partnership NHS Trust

Judy Hart Investors in Excellence

Tammy Holmes West Midlands Academic Health Science Network

Ian Hughes LHM

Melanie Humphreys Birmingham City University

Helen Hunt West Midlands Patient Safety Collaborative

Lisa Inwood Johnson & Johnson

Louise Jackson University of Birmingam

Peter Jeffries West Midlands Patient Safety Collaborative

Marie Jenkins Advance your Wellbeing

Arwyn Jones Beacon Centre

Lisa Jones Medtronic

Jennifer Jones-Rigby Health Exchange CIC LTD

Kerry Kemp Walsall Healthcare NHS Trust

Jeremy Kirk Birmingham Children's Hospital NHS Foundation Trust

Ravi Kumar West Midlands Academic Health Science Network

Linda Magee Greater Manchester Academic Health Science Network

Anoop Maini Strategic Leadership Group for Life Sciences

Mary Matthews Memrica

Karen McCarthy Localise West Midlands

Alastair McIntyre NHS England

Sarah Millard West Midlands Academic Health Science Network

Paul Mills NHS

Sara Minter Abbvie

Jane Moore Coventry City Council

Karen Morrey West Midlands Academic Health Science Network

Neil Mortimer West Midlands Academic Health Science Network

Paddie Murphy PLMCS Ltd

Ian Murray John Taylor Hospice

Sally Naunton Digital Life Sciences

Delegate list


Forename Surname OrganisationPaul Nelson Welbeing

Simon Nevitt Novartis Pharmaceuticals

Laura Pakel Pfizer Ltd

Christopher Parker West Midlands Academic Health Science Network

Suffia Perveen EMC

Michael Phillips Renfrew Group

Adrian Phillips Birmingham City Council

Nick Pope BioSpring Ltd

Angela Priestman Staffordshire University

Jane Pulfer Staffordshire and Stoke-on-Trent Partnership NHS Trust

Joe Robinson Move it or Lose it!

Gregory Rochelle Pfizer Ltd

Mark Rogers Birmingham City Council

Louise Rowan Rowan Communications/University of Birmingham

Paula Rowell Medtronic

Gavin Russell West Midlands Patient Safety Collaborative

Hugo Russell Innovation Birmingham

Kate Salmon NIHR Clinical Research Network West Midlands

Gez Scandrett John Taylor Hospice

Mandy Shanahan Health Education England (West Midlands)

Michael Sheppard West Midlands Academic Health Science Network

Alison Shortman Staffordshire and Stoke-on-Trent Partnership NHS Trust

Fiona Smith Aptvision

Bridget Sproston Novo Nordisk Ltd

Richard Stone Medilink West Midlands

Karen Storey Health Education England (West Midlands)

Megan Strang React Comms

Geraldine Strathdee NHS England

Atif Syed Imobisoft ltd

Peter Templeton Quanta

Alison Tonge NHS Midlands and East

David Trigger Weston Area Health Trust

Ewa Truchanowicz Alta Innovations

Martin Valentine The HCI Group

Stuart Watkins Hospedia

Ben Webber Boilerhouse Communications

Rich Westman Kaido

Terry Whalley Black Country Alliance

Roger Wheelwright John Taylor Hospice

Andy Williams Sandwell and West Birmingham CCG

Kevin Wilson UKTI

Rob Wilson West Midlands Clinical Networks and Senate

Clive Winters Coventry University

Hamid Zolfagharinia Birmingham Community Healthcare NHS Foundation Trust

List correct at time of going to print

Edgbaston Stadium, Birmingham, B5 7QU

15.02.2017

NETWORKING. PRESENTATIONS. EXHIBITIONS. INNOVATION.The West Midlands Academic Health Science Network invite you

to join them for Meridian LIVE.

Offering you the chance to network with potential partners and to explore the latest innovations and advances within the region, as

well as learning about the latest developments in WMAHSN priorities and support and funding mechanisms, this free to

attend event is a must for medical and healthcare professionals in the West Midlands – and beyond!

MERIDIAN LIVE!

w: meridian.wmahsn.org

BRINGING MERIDIAN TO LIFE

West Midlands Academic Health Science Network e: [email protected]

meridian_live.eventbrite.co.ukBOOK TODAY:

West Midlands Academic Health Science

Network

west midlands - wmahsn€¦ · delegate brochure 2016 4 i am delighted to be welcoming so many of...

Documents